Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-22-025484

Chief Financial Officer sold 10,000 shares at $35.00 ($350,000)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gordon Stephen · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-07-05 Exercise or conversion : show line 1 in the form +10,000 $2.21 $22,100 15,714 D
2022-07-05 Sale : show line 2 in the form −10,000 $35.00 $350,000 5,714 D
Open-market sales · 10,000 sh · avg $35.00 · $350,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-07-05 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −10,000 $2.21 2027-06-22 10,000 30,728 D
Loading xslF345X03/doc4.xml…